WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 17.03 Billion CNY | 11.56% |
| 2022 | 15.26 Billion CNY | 48.38% |
| 2021 | 10.29 Billion CNY | 83.35% |
| 2020 | 5.61 Billion CNY | 40.88% |
| 2019 | 3.98 Billion CNY | 57.18% |
| 2018 | 2.53 Billion CNY | 56.56% |
| 2017 | 1.61 Billion CNY | 63.68% |
| 2016 | 989.02 Million CNY | 77.55% |
| 2015 | 557.04 Million CNY | 67.86% |
| 2014 | 331.85 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 8.57 Billion CNY | 0.0% |
| 2023 Q4 | 8.54 Billion CNY | 0.0% |
| 2023 FY | 17.03 Billion CNY | 11.56% |
| 2023 Q2 | 8.49 Billion CNY | 0.0% |
| 2022 FY | 15.26 Billion CNY | 48.38% |
| 2022 Q2 | 7.2 Billion CNY | 0.0% |
| 2022 Q4 | 8.06 Billion CNY | 0.0% |
| 2021 Q4 | 5.88 Billion CNY | 0.0% |
| 2021 Q2 | 4.4 Billion CNY | 0.0% |
| 2021 FY | 10.29 Billion CNY | 83.35% |
| 2020 Q2 | 1.94 Billion CNY | 0.0% |
| 2020 FY | 5.61 Billion CNY | 40.88% |
| 2020 Q4 | 3.66 Billion CNY | 0.0% |
| 2019 FY | 3.98 Billion CNY | 57.18% |
| 2019 Q4 | 2.37 Billion CNY | 0.0% |
| 2019 Q2 | 1.6 Billion CNY | 0.0% |
| 2018 FY | 2.53 Billion CNY | 56.56% |
| 2018 Q4 | 1.48 Billion CNY | 0.0% |
| 2018 Q2 | 1.05 Billion CNY | 0.0% |
| 2017 FY | 1.61 Billion CNY | 63.68% |
| 2017 Q2 | 654.04 Million CNY | 0.0% |
| 2017 Q4 | 964.78 Million CNY | 0.0% |
| 2016 Q2 | 410.13 Million CNY | 0.0% |
| 2016 Q4 | 578.89 Million CNY | 0.0% |
| 2016 FY | 989.02 Million CNY | 77.55% |
| 2015 Q4 | 139.26 Million CNY | 0.0% |
| 2015 FY | 557.04 Million CNY | 67.86% |
| 2015 Q1 | 139.26 Million CNY | 67.86% |
| 2015 Q2 | 139.26 Million CNY | 0.0% |
| 2015 Q3 | 139.26 Million CNY | 0.0% |
| 2014 Q3 | 82.96 Million CNY | 0.0% |
| 2014 Q1 | 82.96 Million CNY | 0.0% |
| 2014 FY | 331.85 Million CNY | 0.0% |
| 2014 Q4 | 82.96 Million CNY | 0.0% |
| 2014 Q2 | 82.96 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -107896.291% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -96670094.654% |
| SQZ Biotechnologies Company | 21.47 Million USD | -79210.248% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -93402.333% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | -13754.189% |
| Mesoblast Limited | 5.9 Million USD | -288518.35% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Genus plc | 668.8 Million USD | -2446.988% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -4152925.002% |
| Marizyme, Inc. | 645.81 Thousand USD | -2637557.361% |
| ContraFect Corporation | - USD | -Infinity% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -22191188.545% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -25916183.776% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -43104953.393% |
| MultiCell Technologies, Inc. | 49.32 USD | -34538229827.007% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -34159.679% |
| EV Biologics, Inc. | 48.9 Thousand USD | -34834777.301% |
| Q BioMed Inc. | 284.35 Thousand USD | -5990452.203% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -57453.992% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 245.31 Million USD | -6843.801% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -24334550.0% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -17207261.052% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -22495086.467% |
| IMV Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -2586726.879% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | -15.958% |
| Halberd Corporation | 999.00 USD | -1705130530.631% |
| Enzolytics Inc. | 52.79 Thousand USD | -32264190.855% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.36 Million USD | -1244184.514% |
| SYBLEU INC | 11.69 Thousand USD | -145641615.116% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -2799169.545% |
| argenx SE | 1.22 Billion USD | -1289.059% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -881590.217% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -2759002.115% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 839.52 Million USD | -1929.025% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | -11639.696% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -3054221.242% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -1707207.918% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -35128.223% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | -101990.749% |
| ONE Bio Corp. | 52.29 Million USD | -32472.642% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -7200717.974% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -7200717.974% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -12146229.202% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -3595672.909% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -218596.302% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -131032630.769% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -43087508.135% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -511439.189% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -255477.719% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -1639385.563% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -66008.802% |
| CSL Limited | 14.8 Billion USD | -15.096% |
| Cellectis S.A. | 755 Thousand USD | -2256092.715% |